Home » Active Biotech AB Releases Results From Phase II/III ANYARA Trial for the Treatment of Renal Cell Cancer
Active Biotech AB Releases Results From Phase II/III ANYARA Trial for the Treatment of Renal Cell Cancer
Active Biotech announced the initial results from the ANYARA Phase II/III clinical study.
4-Traders
4-Traders
Upcoming Events
-
07May
-
14May
-
30May